Form 4 for INSM INSMED Inc
Accepted 2024-05-30 00:00:00 ET · period of report 2024-05-28 · accession 0001628280-24-025895 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2024-05-30 | 2024-05-28 | INSM | Wise John Drayton | Chief Commercial Off | S - Sale+OE | $49.79 | -7,852 | 121.7K | -6% | -$390.9K |
| D | 2024-05-30 | 2024-05-28 | INSM | Wise John Drayton | Chief Commercial Off | M - OptEx | $12.58 | +6,250 | 127.9K | +5% | +$78.6K |
| D | 2024-05-30 | 2024-05-28 | INSM | Wise John Drayton | Chief Commercial Off | M - OptEx | $0.00 | -6,250 | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-05-28 | S | D | 1,602 | $48.95 | 121,657 | D | — | — | |
| 2 | Common | Common Stock | 2024-05-28 | M | A | 6,250 | $12.58 | 127,907 | D | — | — | |
| 3 | Common | Common Stock | 2024-05-28 | S | D | 6,250 | $50.00 | 121,657 | D | — | — | |
| 4 | Derivative | Stock Option (right to buy) | 2024-05-28 | M | D | 6,250 | $0.00 | 0 | D | $12.58 · — to 2024-06-02 | 6,250 Common Stock | (F3) The options became exercisable based on the following vesting schedule: 25% vested on the first anniversary of the grant date and an additional 12.5% vested on each sixth month anniversary date thereafter through the fourth anniversary of the date of grant. All options are currently exercisable. |